Inhibition of TRPM2 results in reduced mitochondrial function and cellular bioenergetics, increased mitochondrial reactive oxygen species (ROS), and impaired survival in ventricular myocytes isolated from both global and cardiac-specific TRPM2 knockout hearts (29, 49) and in neuroblastoma cells (5, 8). Here, TRPM2 is linked to neuroblastoma.